2020 ICD-10-CM Diagnosis Code C19

Malignant neoplasm of rectosigmoid junction

    2016 2017 2018 2019 2020 Billable/Specific Code
  • C19 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2020 edition of ICD-10-CM C19 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of C19 - other international versions of ICD-10 C19 may differ.
Applicable To
  • Malignant neoplasm of colon with rectum
  • Malignant neoplasm of rectosigmoid (colon)
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C19. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • malignant carcinoid tumors of the colon (
    ICD-10-CM Diagnosis Code C7A.02

    Malignant carcinoid tumors of the appendix, large intestine, and rectum

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    C7A.02-
    )
The following code(s) above C19 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C19:
  • C00-D49
    2020 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C15-C26
    2020 ICD-10-CM Range C15-C26

    Malignant neoplasms of digestive organs

    Type 1 Excludes
    • Kaposi's sarcoma of gastrointestinal sites (C46.4)
    Type 2 Excludes
    • gastrointestinal stromal tumors (C49.A-)
    Malignant neoplasms of digestive organs
Approximate Synonyms
  • Cancer of the rectosigmoid junction
  • Cancer of the rectosigmoid, adenocarcinoma
  • Carcinoma of the rectosigmoid junction
  • Colorectal cancer
  • Colorectal cancer, metastatic to brain
  • Colorectal malignant neoplasm metastatic to brain
  • Overlapping malignant neoplasm of colon and rectum
  • Primary adenocarcinoma of rectosigmoid junction
Clinical Information
  • A malignant tumor involving the rectum and sigmoid colon. The majority are carcinomas.
  • A primary or metastatic malignant neoplasm that affects the rectosigmoid area. Representative examples include carcinoma, lymphoma, and sarcoma.
ICD-10-CM C19 is grouped within Diagnostic Related Group(s) (MS-DRG v37.0):
  • 374 Digestive malignancy with mcc
  • 375 Digestive malignancy with cc
  • 376 Digestive malignancy without cc/mcc

Convert C19 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
Code annotations containing back-references to C19:
  • Type 1 Excludes: C18.7
    ICD-10-CM Diagnosis Code C18.7

    Malignant neoplasm of sigmoid colon

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Malignant neoplasm of sigmoid (flexure)
    Type 1 Excludes
    • malignant neoplasm of rectosigmoid junction (C19)
ICD-10-CM Codes Adjacent To C19
C18.0 Malignant neoplasm of cecum
C18.1 Malignant neoplasm of appendix
C18.2 Malignant neoplasm of ascending colon
C18.3 Malignant neoplasm of hepatic flexure
C18.4 Malignant neoplasm of transverse colon
C18.5 Malignant neoplasm of splenic flexure
C18.6 Malignant neoplasm of descending colon
C18.7 Malignant neoplasm of sigmoid colon
C18.8 Malignant neoplasm of overlapping sites of colon
C18.9 Malignant neoplasm of colon, unspecified
C19 Malignant neoplasm of rectosigmoid junction
C20 Malignant neoplasm of rectum
C21 Malignant neoplasm of anus and anal canal
C21.0 Malignant neoplasm of anus, unspecified
C21.1 Malignant neoplasm of anal canal
C21.2 Malignant neoplasm of cloacogenic zone
C21.8 Malignant neoplasm of overlapping sites of rectum, anus and anal canal
C22 Malignant neoplasm of liver and intrahepatic bile ducts
C22.0 Liver cell carcinoma
C22.1 Intrahepatic bile duct carcinoma
C22.2 Hepatoblastoma

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.